Atrial Fibrillation Clinical Trials in the UK: A Complete Guide for 2026
Everything you need to know about atrial fibrillation in the UK, including catheter ablation techniques, novel anticoagulants, left atrial appendage closure devices, and rhythm control strategies. This guide covers what is being tested, who can participate, and how to find trials near you.
Why Atrial Fibrillation Clinical Trials Matter
Clinical trials are essential for developing new treatments for atrial fibrillation. They test whether new drugs, devices, or approaches are safe and effective before they become widely available. In the UK, the NHS actively participates in trials across hundreds of hospitals and research centres, making it one of the best places in the world to access cutting-edge treatments.
For atrial fibrillation patients, trials can offer access to treatments that are not yet available on the NHS, close monitoring by specialist teams, and the opportunity to contribute to medical knowledge that helps future patients.
Current Treatment Landscape
Standard treatment for atrial fibrillation follows established pathways based on disease stage and individual patient factors. For paroxysmal af, the standard approach is rate or rhythm control, catheter ablation, anticoagulation. For persistent af, the standard approach is cardioversion, antiarrhythmic drugs, catheter ablation. For permanent af, the standard approach is rate control, anticoagulation, left atrial appendage closure. For stroke prevention, the standard approach is doacs (apixaban, rivarelbans), warfarin, laao devices.
What Types of Trials Are Available?
Catheter Ablation
Trials testing new ablation technologies including pulsed field ablation (PFA), cryoablation, and RF ablation to isolate the pulmonary veins and restore normal rhythm.
Anticoagulation
Novel anticoagulants (DOACs) and factor XIa inhibitors aim to prevent strokes with lower bleeding risk than traditional warfarin.
Left Atrial Appendage Closure
Device-based alternatives to anticoagulation for patients who cannot tolerate blood thinners. The Watchman and Amulet devices are being studied in UK centres.
Digital & AI Monitoring
Wearable devices and AI algorithms for early AF detection and personalised treatment optimisation. Several UK trials are integrating Apple Watch and Zio patch data.
Who Can Join a Atrial Fibrillation Trial?
Eligibility criteria vary between trials, but common factors include:
- A confirmed diagnosis of atrial fibrillation
- Being at a specific disease stage or treatment line
- Age requirements (most adult trials accept 18+)
- No conflicting medical conditions or medications
- Willingness to attend regular hospital visits
Your specialist can help determine which trials you may be eligible for. You can also use our Smart Matcher tool to find trials based on your specific profile.
How to Find Atrial Fibrillation Trials Near You
There are several ways to find clinical trials for atrial fibrillation in the UK:
- TrialConnect: Use our Atrial Fibrillation condition page to search all recruiting trials, or try the Smart Matcher for personalised matching.
- NHS Be Part of Research: The NHS maintains a searchable database of clinical trials at research sites across the UK.
- Your Specialist: Ask your consultant or clinical nurse specialist about trials at your hospital or local research network.
- NIHR Clinical Research Network: The National Institute for Health Research coordinates trials across England, with equivalent networks in Scotland, Wales, and Northern Ireland.
Frequently Asked Questions
Can I join an AF trial if I am already on blood thinners?
Yes. Many trials specifically recruit patients already taking anticoagulants — testing whether new drugs or devices offer better stroke prevention with fewer side effects.
What is pulsed field ablation?
PFA is a new ablation technique that uses electrical pulses instead of heat or cold to treat AF tissue. It is more selective, causing less collateral damage to surrounding tissues like the oesophagus.
Are AF clinical trials available on the NHS?
Yes. Many NHS hospitals participate in AF trials, especially for ablation techniques and anticoagulation. Your cardiologist can refer you to trials at your local heart centre.
What is left atrial appendage closure?
A minimally invasive procedure that seals off the left atrial appendage — the part of the heart where blood clots most commonly form in AF patients. It is an alternative to long-term blood thinners.
Ready to Find Your Trial?
Search thousands of actively recruiting atrial fibrillation clinical trials across the UK. Our platform is free, instant, and requires no registration.